Takeda Development Center Americas, Inc.
Deerfield, IL, United States
This page shows every FDA and USDA recall linked to Takeda Development Center Americas, Inc.. Each entry includes the product involved, when the recall happened, and how serious it was. If a company has had multiple recalls over the years, you can see the full history here in one place — including whether any were Class I, which is the most serious type.
2
Total Recalls
2018
First Recall
2018
Most Recent
AMITIZA (lubiprostone) capsules 8 mcg. 60-count bottle, Rx Only. Marketed by: Sucampo Pharma Americas, LLC, Ro...
Nov 21, 2018
· Drug
Class III
Terminated
Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet...
Oct 17, 2018
· Drug
Class II
Terminated